Shrey Mathur
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 4
- Epidemiology 11
- Acute Ischemic Stroke Management 6
- Co-authors
- Mike Sharland (7 shared papers)Julia Anna Bielicki (3 shared papers)Aline Fuchs (2 shared papers)Klaus C Fassbender (5 shared papers)Stephan Harbarth (1 shared paper)Mei Fang Zeng (1 shared paper)Sumanth Gandra (1 shared paper)Céline Pulcini (1 shared paper)
- Journals
- Cerebrovascular Diseases (2 papers)Journal of Oncology (2 papers)Neurological Sciences (2 papers)Journal of Community Health (1 paper)Bulletin of the World Health Organization (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Shrey Mathur
25 papers receiving 889 citations
Peers
Comparison fields: 5 of 100
- Applied Microbiology and Biotechnology 153
- Molecular Medicine 60
- Internal Medicine 39
- Epidemiology 358
- Rehabilitation 65
Countries citing papers authored by Shrey Mathur
This map shows the geographic impact of Shrey Mathur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shrey Mathur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shrey Mathur more than expected).
Fields of papers citing papers by Shrey Mathur
This network shows the impact of papers produced by Shrey Mathur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shrey Mathur. The network helps show where Shrey Mathur may publish in the future.
Co-authors
The 25 scholars most cited alongside Shrey Mathur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe | 2018 | 200 |
| 2 | 2018 | 118 | |
| 3 | 2019 | 95 | |
| 4 | 2018 | 89 | |
| 5 | 2019 | 86 | |
| 6 | 2019 | 67 | |
| 7 | 2020 | 61 | |
| 8 | 2019 | 60 | |
| 9 | 2020 | 16 | |
| 10 | 2015 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2020 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2015 | 13 | |
| 15 | 2018 | 11 | |
| 16 | 2021 | 10 | |
| 17 | 2022 | 10 | |
| 18 | 2023 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2022 | 5 |
About Shrey Mathur
Shrey Mathur is a scholar working on Applied Microbiology and Biotechnology, Epidemiology, Internal Medicine, Neurology and Pharmacology, having authored 27 papers that have together received 915 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (6 papers), Antibiotic Use and Resistance (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), COVID-19 and Mental Health (2 papers), Neonatal and Maternal Infections (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (153 citations), Molecular Medicine (60 citations), Internal Medicine (39 citations), Epidemiology (358 citations) and Rehabilitation (65 citations). Shrey Mathur has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Mike Sharland, Julia Anna Bielicki, Aline Fuchs, Klaus C Fassbender, Stephan Harbarth, Mei Fang Zeng, Sumanth Gandra, Céline Pulcini, Nicola Magrini and Johannes N. van den Anker. Their work appears in journals such as Cerebrovascular Diseases, Journal of Oncology, Neurological Sciences, Journal of Community Health and Bulletin of the World Health Organization.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.